SIT Pharma (hereafter \u201cSIT Pharma\u201d) is pleased to announce the acquisition of DINTOINA brand.<\/p>
The product is indicated for generalized epilepsy control, excluding petit mal and partial seizures.<\/p>
Additional clinical uses of the drug are related to the treatment of trigeminal neuralgia, and some forms of cardiac arrhythmia.<\/p>
The acquisition of DINTOINA confirms our will to grow our Italian portfolio in CNS area with essential and well know products and to maintain and assure, to patients and HCP’s, the therapeutic continuity.<\/p>
SIT Pharma is an Italian-based pharmaceutical group with presence in 70 countries which develops, produces and commercializes more than 75 branded pharmaceutical products, Medical Devices and Food supplements.<\/p>
\u00a0<\/p>
About SIT Pharma<\/strong><\/h2>
SIT Pharma is a family-owned pharmaceutical company, based in Italy since 1927, and today is an international pharmaceutical group with\u00a0almost 100 years of experience\u00a0and a recent history of prestigious acquisitions and global expansion. SIT Pharma is a reliable preferred acquirer for pharma businesses choosing to divest their \u201cmature,\u201d \u201cestablished\u201d or \u201ctail\u201d off-patent branded medicines.<\/p>
In its two Italian manufacturing plants, SIT Pharma continues the high-quality \u201cMade in Italy\u201d drug manufacturing and management, aspiring to breathe new life into medicines, investing in them to renew the lifecycle and give new stability and sustainability over the long-term.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"
SIT Pharma is pleased to announce the acquisition of DINTOINA brand. \nThe product is indicated for generalized epilepsy control, excluding petit mal and partial seizures.<\/p>\n","protected":false},"author":2,"featured_media":11016,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[95],"tags":[],"class_list":["post-11022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-eng"],"yoast_head":"\n
SIT Pharma acquires DINTOINA - Sitpharma - Italia<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\t\n\t\n\t\n